Padlock will bring powerful new medicines to patients by developing drugs targeting the PAD enzymes.
We will focus first on the role of PADs in generating neoantigens in destructive autoimmune diseases.
Our long-term goal is to explore the full biological and therapeutic footprint of protein citrullination.